Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma

详细信息    查看全文

• 作者：Mi Jin Gu (1)
  Byung Ik Jang (2)
  
• 关键词：Intrahepatic cholangiocarcinoma ; Sox2 ; CD44 ; CD44v6 ; Survival
• 刊名：Pathology & Oncology Research
• 出版年：2014
• 出版时间：July 2014
• 年：2014
• 卷：20
• 期：3
• 页码：655-660
• 全文大小：
• 参考文献：1. Zhang C, Bai DS, Huang XY et al (2013) Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. PLoS One 8:e54619 CrossRef
  2. Ruan J, Wei B, Xu Z et al (2013) Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer. Med Oncol 30:445. doi:10.1007/s12032-012-0445-z CrossRef
  3. Guo Y, Liu S, Wang P et al (2011) Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59:763-75 CrossRef
  4. Ling GQ, Chen DB, Wang BQ et al (2012) Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines. Oncol Lett 4:1264-268
  5. Ben-Porath I, Thomson MW, Carey VJ et al (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499-07 CrossRef
  6. Kitamura H, Torigoe T, Hirohashi Y et al (2013) Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol 26:117-24 CrossRef
  7. Brcic L, Sherer CK, Shuai Y et al (2012) Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2. Am J Clin Pathol 138:712-18 CrossRef
  8. Neumann J, Bahr F, Horst D et al (2011) SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11:518. doi:10.1186/1471-2407-11-518 CrossRef
  9. Lengerke C, Fehm T, Kurth R et al (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11:42. doi:10.1186/1471-2407-11-42 CrossRef
  10. Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G et al (2007) Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol 20:474-81 CrossRef
  11. Han X, Fang X, Lou X et al (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 7:e41335 CrossRef
  12. Huang P, Qiu J, Li B et al (2011) Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem 44:582-89 CrossRef
  13. Wilbertz T, Wagner P, Petersen K et al (2011) SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 24:944-53 CrossRef
  14. Velcheti V, Schalper K, Yao X et al (2013) High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One 8:e61427 CrossRef
  15. Otsubo T, Akiyama Y, Yanagihara K et al (2008) SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 98:824-31 CrossRef
  16. Matsuoka J, Yashiro M, Sakurai K et al (2012) Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 174:130-35 CrossRef
  17. Nanashima A, Hatachi G, Tsuchiya T et al (2013) Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. Anticancer Res 33:2107-114
  18. Wakamatsu Y, Sakamoto N, Oo HZ et al (2012) Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 62:112-19 CrossRef
  19. Palagani V, El Khatib M, Krech T et al (2012) Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer. Anticancer Res 32:1747-755
  20. Okayama H, Kumamoto K, Saitou K et al (2009) CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep 22:745-55
  21. Klatte T, Seligson DB, Rao JY et al (2010) Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol 183:2403-408 CrossRef
  22. Sun C, Sun L, Li Y et al (2013) Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug. Med Oncol 30:503. doi:10.1007/s12032-013-0503-1 CrossRef
  23. Pongcharoen P, Jinawath A, Tohtong R (2011) Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells. Clin Exp Metastasis 28:827-39 CrossRef
  24. Zlobec I, Gunthert U, Tornillo L, Iezzi G, Baumhoer D, Terracciano L et al (2009) Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Histopathology 55:564-75 CrossRef
  25. Avoranta ST, Korkeila EA, Syrjanen KJ et al (2012) Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence. World J Gastroenterol 18:4549-556 CrossRef
  26. da Cunha CB, Oliveira C, Wen X et al (2010) De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Investig 90:1604-614 CrossRef
  27. Afify AM, Tate S, Durbin-Johnson B et al (2011) Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors. Int J Biol Markers 26:50-7 CrossRef
  28. Ashida K, Terada T, Kitamura Y et al (1998) Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 27:974-82 CrossRef
  
• 作者单位：Mi Jin Gu (1)
  Byung Ik Jang (2)
  
  1. Department of Pathology, College of Medicine, Yeungnam University, 170, Hyeonchung-ro, Nam-gu, Daegu, Republic of Korea
  2. Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea
  
• ISSN：1532-2807

文摘

Embryonic stem cells (ESC) and cancer stem cells (CSC) have a capacity for self-renewal and differentiation into multiple cell lineages. Sox2 plays a critical role in ESC and has been shown to participate in carcinogenesis and tumor progression in many human cancers. CD44 and CD44v6 are putative CSC markers and their association with tumor progression, metastasis, and tumor relapse after treatment has been demonstrated. We evaluated the immunoexpression of Sox2, CD44, and CD44v6 in 85 cases of Intrahepatic cholangiocarcinomas (IHCC) and assessed their prognostic significance. Sox2 expression showed a significant association with lymph node metastasis (p--.025), T4 stage (p--.046), and worse overall survival (p--.047). Greater expression of Sox2 was observed in IHCC with poor differentiation, vascular invasion, and stage IV, without statistical significance (p-gt;-.05). CD44 expression showed an association with periductal infiltrative type (p--.034), poor differentiation (p--.012), and vascular invasion (p--.009). CD44v6 expression was evident in patients with stage IV (p--.019). These results demonstrated that Sox2 expression is associated with aggressive behavior and poor overall survival in IHCC.